Non-Hodgkin Lymphoma, Relapsed
1 clinical trials · Condition
◉ Watch Non-Hodgkin Lymphoma, Relapsed
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma (NCT05798897) | Marker Therapeutics, Inc. | 2023-01-02 |
Track Non-Hodgkin Lymphoma, Relapsed automatically
Every clearance here is in the API, with alerts when new ones post.